U.S. Markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
174.07+3.22 (+1.88%)
At close: 4:00PM EDT

174.09 0.02 (0.01%)
After hours: 7:54PM EDT

People also watch
Full screen
Previous Close170.85
Bid174.09 x 100
Ask175.00 x 100
Day's Range170.83 - 174.54
52 Week Range133.64 - 184.21
Avg. Volume3,476,170
Market Cap128.01B
PE Ratio (TTM)16.53
Earnings DateN/A
Dividend & Yield4.60 (2.65%)
Ex-Dividend Date2017-05-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals4 hours ago

    After FDA delay, Peninsula 'biosimilar' company sheds third of workforce

    Coherus BioSciences Inc., stopped earlier this month in its efforts to offer a lower-cost version of a drug for cancer chemotherapy patients, will lay off 30 percent of its workforce. The Redwood City company (CHRS) said it cut 51 jobs after the Food and Drug Administration asked it to reanalyze some data from clinical trials and provide more information about manufacturing. Coherus leaders had hoped to win FDA approval this month of the drug, its version of Amgen Inc.'s Neulasta, and hit the market as soon as the end of this year.

  • Investopedia9 hours ago

    July's Tough, but These Stocks Tend to Do Well

    July isn't a great month for the stock market historically, but these stocks tend to perform well.

  • The Wall Street Journal9 hours ago

    [$$] HGGC Backs Provider of Data-Visualization Software

    Denodo Technologies Inc.’s founder and senior management team will retain an ownership stake in the company.